Research
CHM evaluation: Transient embryonic hypoxia and teratogenicity with HPTs
Published 2025-09-01.
MHRA assessment of transient embryonic hypoxia and teratogenicity in relation to oral hormone pregnancy tests (HPTs), as considered by the Commission on Human Medicines (CHM).
§ Publishing organisations